Research Article| Volume 17, ISSUE 2, P101-111, September 1993

Effects of oophorectomy and hormone replacement therapy on pituitary-gonadal function

      This paper is only available as a PDF. To read, Please Download here.


      The purpose of this study was to determine how oophorectomy and different hormone replacement therapy (HRT) regimens using low doses of medroxyprogesterone acetate (MPA, 2.5 mg/day) influence the pituitary-gonadal axis function. Ninety (90) women, who had had regular menses prior to surgery, completed a I-year follow-up period. Patients were assigned to 5 groups. The first (n = 16) received 0.625 mg/day conjugated equine oestrogens (CEE) cyclically, the second (n = 20) 50 μday transdermal oestradiol (E2) cyclically and the third (n = 15) 0.625 mg/day CEE continuously. These 3 groups also received 2.5 mg MPA sequentially for the last 12 days of HRT administration. The fourth group (n = 20) received 0.625 mg/day CEE and 2.5 mg/day of MPA continuously, while the fifth (n = 19) constituted a control group. After oophorectomy all patients showed increases in follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels, and decreases in those of E2, oestrone (E1), prolactin (PRL), sex-hormone-binding globulin (SHBG), androstenedione (ΔA4) and testosterone (T). No changes were detected in dehydroepiandrosterone sulphate (DHEA-S) levels. After HRT, decreases′ in FSH, LH and PRL levels and increases in those of E2, E1 and SHBG were observed, but no changes were seen in T, ΔA4 or DHEA-S plasma levels. As the differences that were found cannot be attributed to the presence of ovaries, it is reasonable to assume that they were perhaps due to the treatment. All these changes, with the exception of a decrease in PRL levels, are therefore to be expected after HRT.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Norman AW
        • Litwack G
        Estrogens and progestins.
        in: Hormones. Academic Press, San Diego1987: 515-564
        • Adler NT
        Neuroendocrinology of reproduction.
        in: Plenum Press, New York1981: 123-125
        • Knobil E
        • Wildt L
        Neuroendocrine control of ovarian function in higher primates.
        in: Leyendecker G Stock H Wildt L Brain and pituitary peptides II. Karger, Munich1983: 11-30
        • Garza-Flores J
        • Alba VM
        • Cravioto MC
        • Hernandez L
        • Perez-Palacios G
        Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
        Contraception. 1989; 39: 519-529
        • Badawy SZA
        • Rebscher F
        • Kohn L
        • Wolfe H
        • Oates RP
        • Moses A
        The relation between oral contraceptive use and subsequent development of hyperprolactinemia.
        Fertil Steril. 1981; 36: 464-467
        • Vekemans M
        • Robyn C
        The influence of exogenous estrogen on the circadian periodicity of circulating prolactin in women.
        J Clin Endocrinol Metab. 1975; 40: 886-889
        • Notelovitz M
        • Ware M
        • Buhi W
        • Dougherty M
        Prolactin: effects of age, menopausal status and exogenous hormones.
        Am J Obstet Gynecol. 1982; 143: 225-227
        • Moguilevsky JA
        • Wiemeyer JMC
        • Sagasta CL
        • Leiderman S
        Estrogenic activities of estradiol enantate and ethinyl-estradiol compared at a clinical level.
        Arzneim Forsch Drug Res. 1986; 36: 1671-1674
        • Mathur RS
        • Landgrebe SC
        • Moody LO
        • Semmens JP
        • Williamson HO
        The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormonebinding globulin in post-menopausal women.
        Maturitas. 1985; 7: 129-133
        • Hirvonen E
        • Elliesen J
        • Schmidt-Gollwitzer K
        Comparison of two hormone replacement regimensinfluence on lipo-proteins and bone mineral content.
        Maturitas. 1990; 12: 127-136
        • Castelo-Branco C
        • Fusté P
        • Martinez de Osaba MJ
        • González-Merlo J
        Hormone replacement therapy and changes on pituitary function.
        Eur J Obstet Gynecol Reprod Biol. 1992; 43: 59-63
        • Cooke ID
        Endocrine changes associated with the menopause and post-menopausal years.
        in: Campbell S The management of the menopause and post-menopausal years. 1976: 49-62
        • McPherson III, JC
        • Costoff A
        • Mahesh VB
        Influence of estrogen-progesterone combinations on gonadotrophin secretion in castrated female rats.
        Endocrinology. 1975; 97: 771-774
        • Yen SSC
        • Martin PL
        • Burnier AM
        • Czekala NM
        • Greaney Jr, MO
        • Callentine MR
        Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women.
        J Clin Endocrinol Metab. 1975; 40: 518-521
        • Frantz AG
        • Kleinberg DL
        • Noel GL
        Studies on prolactin in man.
        Rec Prog Horm Res. 1972; 28: 527-531
        • Yen SSC
        • Ehara Y
        • Siler TM
        Augmentation of prolactin secretion by estrogen in hypogonadal women.
        J Clin Invest. 1974; 53: 652-655
        • Del Pozo E
        • Bownell J
        • Prolactin I
        Mechanisms of control, peripheral actions and modification by drugs.
        Horm Res. 1979; 10: 143-172
        • Frantz AG
        N Engl J Med. 1978; 298: 201-207
        • Jordan VC
        • Koch R
        Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivates of estradiol and estrone.
        Endocrinology. 1989; 124: 1717-1726
        • Brann DW
        • Putnam CD
        • Mahesh VB
        Antagonism of estrogen-induced prolactin release by dihydrotestosterone.
        Biol Reprod. 1989; 40: 1201-1207
        • Smanik E
        • Young K
        • Muldoon TG
        • Mahesh VB
        Analysis of the effect of progesterone in vivo on estrogen receptor distribution in the rat anterior pituitary and hypothalamus.
        Endocrinology. 1983; 113: 15-22
        • Judd HL
        • Lucas WE
        • Yen SSC
        Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer.
        Am J Obstet Gynecol. 1974; 118: 793-798
        • Judd HL
        • Judd GE
        • Lucas WE
        • Yen SSC
        Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.
        J Clin Endocrinol Metab. 1974; 39: 1020-1024
        • Vermeulen A
        The hormonal activity of the postmenopausal ovary.
        J Clin Endocrinol Metab. 1976; 42: 247-253